The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens (2017)
Attributed to:
A novel vaccine for broad protection against meningococcal disease: progression to phase I clinical trial
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-017-01421-z
PubMed Identifier: 28496136
Publication URI: http://europepmc.org/abstract/MED/28496136
Type: Journal Article/Review
Parent Publication: Scientific Reports
Issue: 1
ISSN: 2045-2322